FDA approves Biohaven Phase 2 trial re COVID-19
The IND was approved by the Division of Pulmonary, Allergy, and Critical Care at FDA on and Biohaven was informed that the study may proceed...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
The IND was approved by the Division of Pulmonary, Allergy, and Critical Care at FDA on and Biohaven was informed that the study may proceed...
CSL Behring and SAB Biotherapeutics are partnering to combat the coronavirus pandemic with the rapid development of SAB-185, a COVID-19 therapeutic candidate on track for clinical evaluation...
With certified face masks at a critical shortage, a team of researchers at the Yale School of Engineering & Applied Science are developing a system to...
Connecticut’s Lee Company, with technical centers in Essex and Westbrook, is partnering with General Motors and Ventec to mass produce ventilators … more A Manchester,...
Cybrexa Therapeutics reports that Arthur DeCillis, MD, has joined the company as Acting Chief Medical Officer. Dr. DeCillis will be responsible for the development of...
As part of a commitment to fighting the COVID-19 pandemic and its long-standing partnership with the pulmonology community, Boehringer Ingelheim is donating $500,000 to the American...
Sema4 is performing rapid molecular testing for the detection of SARS-CoV-2, the coronavirus responsible for COVID-19. Sema4 is partnering with the state of Connecticut and...
Vanessa Research has begun manufacturing a hand sanitizer according to formulation guidelines from the World Health Organization and the FDA. The hand sanitizer, KLAREX Cleanse™,...
The collaborative efforts of medical doctors from UConn Health with engineers, scientists, and researchers from Storrs will soon result in an increased supply of personal protective equipment...
Intensity Therapeutics reports successful completion of the safety lead in portion of the IT-01 KEYNOTE A10 study arm (NCT03058289) that is testing the combination of...